Literature DB >> 17125675

[Streptococcus agalactiae highly resistant to fluoroquinolones].

Elisenda Miró1, Montserrat Rebollo, Alba Rivera, M Teresa Alvarez, Ferrán Navarro, Beatriz Mirelis, Pere Coll.   

Abstract

BACKGROUND: Streptococcus agalactiae remains susceptible to penicillin; nevertheless, an increase in the resistance to other antimicrobial families, such as macrolides and more rarely fluoroquinolones, has been described. METHODS AND
RESULTS: From 2003 to 2004, two fluoroquinolone-resistant S. agalactiae strains were detected. The strains presented one mutation in parC (Ser79 --> Phe) and an additional mutation in gyrA (Glu85 --> Ala or Glu85 --> Lys).
CONCLUSION: This study describes the first S. agalactiae strains highly resistant to fluoroquinolones in Spain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125675     DOI: 10.1157/13093876

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  6 in total

1.  Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

Authors:  G Piccinelli; F Gargiulo; S Corbellini; G Ravizzola; C Bonfanti; A Caruso; M A De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

2.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

3.  Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.

Authors:  Hsiu-Mei Wu; Rajendra Prasad Janapatla; Yueh-Ren Ho; Kuei-Hsiang Hung; Chi-Wen Wu; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

4.  Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.

Authors:  Somay Yamagata Murayama; Chizuko Seki; Hiroshi Sakata; Katsuhiko Sunaoshi; Eiichi Nakayama; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

5.  Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.

Authors:  Asmaa Tazi; Thomas Gueudet; Emanuelle Varon; Liliane Gilly; Patrick Trieu-Cuot; Claire Poyart
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

6.  Detection of Group B Streptococcus in Brazilian pregnant women and antimicrobial susceptibility patterns.

Authors:  Didier Silveira Castellano-Filho; Vânia Lúcia da Silva; Thiago César Nascimento; Marcel de Toledo Vieira; Cláudio Galuppo Diniz
Journal:  Braz J Microbiol       Date:  2010-12-01       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.